X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 clinical trials

Explore recruiting x linked immunodeficiency with hyper igm type 1 higm1 clinical trials.

Also recruiting in Europe

X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open Label, Single Arm, Phase I/II Clinical Study of Autologous CD4+ T-Cells Edited Ex-Vivo at the CD40LG Locus by CRISPR/Cas9 and IDLV-based vector in Patients with X-linked Hyper IgM Syndrome Type 1 (HIGM1)

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 trials by city

X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in Toronto X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in Vancouver X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in Montreal X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in Calgary X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in Edmonton X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in Ottawa X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in Winnipeg X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in Quebec City X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in Hamilton X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in Kitchener X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in London X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in Halifax X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in New York X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in Los Angeles X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in Chicago X Linked Immunodeficiency With Hyper Igm Type 1 Higm1 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease